Ticker BCEL – Atreca – sales, description, marketcap – Tickerday.com

BCEL

Atreca

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 447.92M; Volume: 206.94K; AvgVol 3m: 333.59K; Beta: ;

Cost estimate:

P/E: ; EPS: -2.68; EPS growth quarter/prev quarter: -6.10%;

EPS growth this year: -70.30%; EPS growth past 5 years: ;

EPS ttm: -2.73;

P/S: ; P/B: 2.70; P/Cashflow: 3.21; P/FCF: ;

Sales: ; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -40.60%; ROE – return on equity: -42.70%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 1.40%; Insider Transactions:-27.77%;

Institutional Ownership: 67.50%; Institutional Transactions: 4.00%;

Data update: 07/10/2020.

Leave a comment

Your email address will not be published. Required fields are marked *